The transcriptional profiling of the target tissues in T1D, HT, and CD showed up-regulation of autoimmunity-related pathways, such as intestinal immune network for IgA production, T1D, allograft rejection, and graft-versus-host disease. The gene discussed is CD79A; the disease is type 1 diabetes mellitus.